{"id":"https://openalex.org/W4362477396","doi":"https://doi.org/10.1158/1535-7163.22497888.v1","title":"Supplementary Figure 1 from Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model","display_name":"Supplementary Figure 1 from Crizotinib, a c-Met Inhibitor, Prevents Metastasis in a Metastatic Uveal Melanoma Model","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362477396","doi":"https://doi.org/10.1158/1535-7163.22497888.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22497888.v1","doi":"https://doi.org/10.1158/1535-7163.22497888.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22497888.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Crizotinib_a_c-Met_Inhibitor_Prevents_Metastasis_in_a_Metastatic_Uveal_Melanoma_Model/22497888/1/files/39956241.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Crizotinib_a_c-Met_Inhibitor_Prevents_Metastasis_in_a_Metastatic_Uveal_Melanoma_Model/22497888/1/files/39956241.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5079178474","display_name":"Oliver Surriga","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Oliver Surriga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069187383","display_name":"Vinagolu K. Rajasekhar","orcid":"https://orcid.org/0000-0002-7364-2675","observed_orcids":["https://orcid.org/0000-0002-7364-2675"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Vinagolu K. Rajasekhar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026962347","display_name":"Grazia Ambrosini","orcid":"https://orcid.org/0000-0002-3051-362X","observed_orcids":["https://orcid.org/0000-0002-3051-362X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Grazia Ambrosini","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045999796","display_name":"Yildrim Dogan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yildrim Dogan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035464945","display_name":"Ruimin Huang","orcid":"https://orcid.org/0000-0001-9369-0263","observed_orcids":["https://orcid.org/0000-0001-9369-0263"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruimin Huang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006913373","display_name":"Gary K. Schwartz","orcid":"https://orcid.org/0000-0003-1813-5061","observed_orcids":["https://orcid.org/0000-0003-1813-5061"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gary K. Schwartz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11328","display_name":"Ocular Oncology and Treatments","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11149","display_name":"Veterinary Oncology Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/c-met-inhibition","display_name":"c-Met inhibition","score":0.8550000190734863},{"id":"https://openalex.org/keywords/uveal-melanoma","display_name":"uveal melanoma","score":0.8840000033378601},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.8740000128746033},{"id":"https://openalex.org/keywords/anaplastic-lymphoma-kinase","display_name":"anaplastic lymphoma kinase","score":0.8119999766349792},{"id":"https://openalex.org/keywords/ros1","display_name":"ROS1","score":0.9990000128746033},{"id":"https://openalex.org/keywords/sirna-knockdown","display_name":"siRNA knockdown","score":0.8930000066757202},{"id":"https://openalex.org/keywords/cell-migration","display_name":"cell migration","score":0.7900000214576721},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.932431161403656},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6114635467529297},{"id":"https://openalex.org/C2775999482","wikidata":"https://www.wikidata.org/wiki/Q18031208","display_name":"ROS1","level":4,"score":0.5573312640190125},{"id":"https://openalex.org/C173396325","wikidata":"https://www.wikidata.org/wiki/Q1501275","display_name":"Gene knockdown","level":3,"score":0.5485305786132812},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.5349658131599426},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5057828426361084},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.5011963844299316},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.432227224111557},{"id":"https://openalex.org/C2775832928","wikidata":"https://www.wikidata.org/wiki/Q407954","display_name":"Expanded access","level":2,"score":0.4308055341243744},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37012869119644165},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.24076032638549805},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.18339455127716064},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.16909465193748474},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.11608952283859253},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07112133502960205},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.0646485686302185},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.22497888.v1","doi":"https://doi.org/10.1158/1535-7163.22497888.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22497888.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Crizotinib_a_c-Met_Inhibitor_Prevents_Metastasis_in_a_Metastatic_Uveal_Melanoma_Model/22497888/1/files/39956241.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22497888","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Crizotinib_a_c-Met_Inhibitor_Prevents_Metastasis_in_a_Metastatic_Uveal_Melanoma_Model/22497888","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22497888.v1","doi":"https://doi.org/10.1158/1535-7163.22497888.v1","is_oa":true,"landing_page_url":"http://dx.doi.org/10.1158/1535-7163.22497888.v1","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_1_from_Crizotinib_a_c-Met_Inhibitor_Prevents_Metastasis_in_a_Metastatic_Uveal_Melanoma_Model/22497888/1/files/39956241.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362477396.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392681118","https://openalex.org/W2163037808","https://openalex.org/W2065646627","https://openalex.org/W1992393321","https://openalex.org/W2315358795","https://openalex.org/W6902485473","https://openalex.org/W2326495333","https://openalex.org/W2999577741","https://openalex.org/W2564428923","https://openalex.org/W4384816327"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"805K,":[3],"Supplementary":[4],"Figure":[5],"1:":[6],"Effects":[7],"of":[8],"c-Met,":[9],"ALK":[10],"and":[11],"ROS1":[12],"knockdown":[13],"by":[14],"siRNA":[15],"on":[16],"cell":[17],"migration.":[18]},"counts_by_year":[],"updated_date":"2026-09-04T10:56:28.161419","created_date":"2023-04-05T00:00:00"}